It should be noted that samples with ctDNA TF < 1% were frequent in our study (52.6% of the total liquid biopsy cohort; 42.9% of the paired cohort) and in previous studies of patients with breast cancer (26.3%–31.2%) [27, 32]. This evidence concerns the gene TF and breast carcinoma.